Price T Rowe Associates Inc Novo Nordisk A S Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Price T Rowe Associates Inc holds 6,345,118 shares of NVO stock, worth $522 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,345,118
Previous 9,583,435
33.79%
Holding current value
$522 Million
Previous $1.14 Billion
52.17%
% of portfolio
0.06%
Previous 0.13%
Shares
9 transactions
Others Institutions Holding NVO
# of Institutions
1,876Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.64 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.28 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.07 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.04 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $186B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...